Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, IL
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Efficacy and Safety Trial of Bapineuzumab (AAB-001) in Subjects with Mild to Moderate Alzheimer’s Disease who are Apolipoprotein E e4 Carriers
The purpose of this study is to test if bapineuzumab is effective and safe in treating Alzheimer’s Disease. This will be done during this study using tests that show how you are doing over time with memory, day to day activities, and other measures of brain function and disease.
Please contact Alexian Brothers for more information on participation.
Alexian Brothers Hospital Network
800 Biesterfield Road
Brock Building First Floor
Elk Grove Village, IL 60007
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these